INFORMAZIONI SU QUESTO ARTICOLO

Cita

Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45. 10.1016/j.radonc.2004.12.015Haie-MederCPotterRVan LimbergenEBriotEDe BrabandereMDimopoulosJRecommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTVRadiother Oncol2005742354510.1016/j.radonc.2004.12.015Open DOISearch in Google Scholar

Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012; 82: 250-5. 10.1016/j.ijrobp.2010.10.030ViswanathanANCreutzbergCLCraigheadPMcCormackMToitaTNarayanKInternational brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)Int J Radiat Oncol Biol Phys201282250510.1016/j.ijrobp.2010.10.030Open DOISearch in Google Scholar

Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-23. 10.1016/j.radonc.2011.07.012PotterRGeorgPDimopoulosJCGrimmMBergerDNesvacilNClinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancerRadiother Oncol20111001162310.1016/j.radonc.2011.07.012Open DOISearch in Google Scholar

Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 2014; 135: 231-8. 10.1016/j.ygyno.2014.08.027RijkmansECNoutRARuttenIHKetelaarsMNeelisKJLamanMSImproved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapyGynecol Oncol2014135231810.1016/j.ygyno.2014.08.027Open DOISearch in Google Scholar

Potter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60. 10.1016/j.ctro.2018.01.001PotterRTanderupKKirisitsCde LeeuwAKirchheinerKNoutRThe EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studiesClin Transl Radiat Oncol20189486010.1016/j.ctro.2018.01.001Open DOISearch in Google Scholar

Mohamed S, Kallehauge J, Fokdal L, Lindegaard JC, Tanderup K. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Brachytherapy 2015; 14: 23-8. 10.1016/j.brachy.2014.09.010MohamedSKallehaugeJFokdalLLindegaardJCTanderupK.Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapyBrachytherapy20151423810.1016/j.brachy.2014.09.010Open DOISearch in Google Scholar

Marnitz S, Kohler C, Burova E, Wlodarczyk W, Jahn U, Grun A, et al. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity. Int J Radiat Oncol Biol Phys 2012; 82: e137-43. 10.1016/j.ijrobp.2010.10.066MarnitzSKohlerCBurovaEWlodarczykWJahnUGrunAHelical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicityInt J Radiat Oncol Biol Phys201282e1374310.1016/j.ijrobp.2010.10.066Open DOISearch in Google Scholar

Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77. 10.1016/j.radonc.2005.11.014PotterRHaie-MederCVan LimbergenEBarillotIDe BrabandereMDimopoulosJRecommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiologyRadiother Oncol200678677710.1016/j.radonc.2005.11.014Open DOISearch in Google Scholar

Hinz A, Singer S, Brahler E. European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol 2014; 53: 958-65. 10.3109/0284186x.2013.879998HinzASingerSBrahlerE.European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studiesActa Oncol2014539586510.3109/0284186x.2013.879998Open DOISearch in Google Scholar

Lee Y, Lim MC, Kim SI, Joo J, Lee DO, Park SY. Comparison of quality of life and sexuality between cervical cancer survivors and healthy women. Cancer Res Treat 2016; 48: 1321-9. 10.4143/crt.2015.425LeeYLimMCKimSIJooJLeeDOParkSY.Comparison of quality of life and sexuality between cervical cancer survivors and healthy womenCancer Res Treat2016481321910.4143/crt.2015.425Open DOISearch in Google Scholar

Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer 2007; 110: 2716-25. 10.1002/cncr.23094ParkSYBaeDSNamJHParkCTChoCHLeeJMQuality of life and sexual problems in disease-free survivors of cervical cancer compared with the general populationCancer200711027162510.1002/cncr.23094Open DOISearch in Google Scholar

Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Pre 2012; 21: 2108-17. 10.1158/1055-9965.EPI-12-0740WeaverKEForsytheLPReeveBBAlfanoCMRodriguezJLSabatinoSAMental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview SurveyCancer Epidemiol Biomarkers Pre20122121081710.1158/1055-9965.EPI-12-0740Open DOISearch in Google Scholar

Kirchheiner K, Potter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petric P, et al. Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2016; 94: 1088-98. 10.1016/j.ijrobp.2015.12.363KirchheinerKPotterRTanderupKLindegaardJCHaie-MederCPetricPHealth-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE studyInt J Radiat Oncol Biol Phys20169410889810.1016/j.ijrobp.2015.12.363Open DOISearch in Google Scholar

Kim Y, Kim YJ, Kim JY, Lim YK, Jeong C, Jeong J, et al. Toxicities and dosevolume histogram parameters of MRI-based brachytherapy for cervical cancer. Brachytherapy 2017; 16: 116-25. 10.1016/j.brachy.2016.10.005KimYKimYJKimJYLimYKJeongCJeongJToxicities and dosevolume histogram parameters of MRI-based brachytherapy for cervical cancerBrachytherapy2017161162510.1016/j.brachy.2016.10.005Open DOISearch in Google Scholar

Mazeron R, Maroun P, Castelnau-Marchand P, Dumas I, del Campo ER, Cao K, et al. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: dose-volume effect relationships for the rectum and bladder. Radiother Oncol 2015; 116: 226-32. 10.1016/j.radonc.2015.06.027MazeronRMarounPCastelnau-MarchandPDumasIdel CampoERCaoKPulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: dose-volume effect relationships for the rectum and bladderRadiother Oncol20151162263210.1016/j.radonc.2015.06.027Open DOISearch in Google Scholar

Foerster R, Schnetzke L, Bruckner T, Arians N, Rief H, Debus J, et al. Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer. Strahlenther Onkol 2016; 192: 895-904. 10.1007/s00066-016-1037-1FoersterRSchnetzkeLBrucknerTAriansNRiefHDebusJPrognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancerStrahlenther Onkol201619289590410.1007/s00066-016-1037-1Open DOISearch in Google Scholar

Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001; 61: 223-31. 10.1016/S0167-8140(01)00429-7DorrWHendryJH.Consequential late effects in normal tissuesRadiother Oncol2001612233110.1016/S0167-8140(01)00429-7Open DOISearch in Google Scholar

Rajasooriyar C, Van Dyk S, Lindawati M, Bernshaw D, Kondalsamy-Chennakesavan S, Narayan K. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography. Int J Gynecol Cancer 2012; 22: 1532-7. 10.1097/IGC.0b013e31826c4deeRajasooriyarCVan DykSLindawatiMBernshawDKondalsamy-ChennakesavanSNarayanK.Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomographyInt J Gynecol Cancer2012221532710.1097/IGC.0b013e31826c4deeOpen DOISearch in Google Scholar

Huang EY, Lin H, Hsu HC, Wang CJ, Chen HC, Sun LM, et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 2000; 79: 406-10. 10.1006/gyno.2000.5997HuangEYLinHHsuHCWangCJChenHCSunLMHigh external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancerGynecol Oncol2000794061010.1006/gyno.2000.5997Open DOISearch in Google Scholar

Huang EY, Wang CJ, Hsu HC, Hao L, Chen HC, Sun LM. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose. Gynecol Oncol 2004; 95: 101-8. 10.1016/j.ygyno.2004.06.043HuangEYWangCJHsuHCHaoLChenHCSunLM.Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal doseGynecol Oncol200495101810.1016/j.ygyno.2004.06.043Open DOISearch in Google Scholar

Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Potter R, Lindegaard J, et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1572-9. 10.1016/j.ijrobp.2010.05.031FenkellLAssenholtMNielsenSKHaie-MederCPotterRLindegaardJParametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancerInt J Radiat Oncol Biol Phys2011791572910.1016/j.ijrobp.2010.05.031Open DOISearch in Google Scholar

Boyle J, Craciunescu O, Steffey B, Cai J, Chino J. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies. Gynecol Oncol 2014; 135: 239-43. 10.1016/j.ygyno.2014.08.037BoyleJCraciunescuOSteffeyBCaiJChinoJ.Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignanciesGynecol Oncol20141352394310.1016/j.ygyno.2014.08.037Open DOISearch in Google Scholar

Sturdza A, Potter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-33. 10.1016/j.radonc.2016.03.011SturdzaAPotterRFokdalLUHaie-MederCTanLTMazeronRImage guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort studyRadiother Oncol20161204283310.1016/j.radonc.2016.03.011Open DOISearch in Google Scholar

Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2014; 89: 88-95. 10.1016/j.ijrobp.2014.01.032KirchheinerKNoutRATanderupKLindegaardJCWesterveldHHaie-MederCManifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE studyInt J Radiat Oncol Biol Phys201489889510.1016/j.ijrobp.2014.01.032Open DOISearch in Google Scholar

Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, et al. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol 2016; 118: 160-6. 10.1016/j.radonc.2015.12.025KirchheinerKNoutRALindegaardJCHaie-MederCMahantshettyUSegedinBDose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE studyRadiother Oncol2016118160610.1016/j.radonc.2015.12.025Open DOISearch in Google Scholar

Mohamed S, Lindegaard JC, de Leeuw AA, Jurgenliemk-Schulz I, Kirchheiner K, Kirisits C, et al. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol 2016; 120: 480-5. 10.1016/j.radonc.2016.05.020MohamedSLindegaardJCde LeeuwAAJurgenliemk-SchulzIKirchheinerKKirisitsCVaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancerRadiother Oncol2016120480510.1016/j.radonc.2016.05.020Open DOISearch in Google Scholar

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43. 10.1056/nejm199904153401501MorrisMEifelPJLuJGrigsbyPWLevenbackCStevensREPelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancerN Engl J Med199934011374310.1056/nejm199904153401501Open DOISearch in Google Scholar

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53. 10.1056/nejm199904153401502RosePGBundyBNWatkinsEBThigpenJTDeppeGMaimanMAConcurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancerN Engl J Med199934011445310.1056/nejm199904153401502Open DOISearch in Google Scholar

Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemoradiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol 2013; 107: 69-74. 10.1016/j.radonc.2013.04.006NomdenCNde LeeuwAARoesinkJMTersteegRJMoerlandMAWitteveenPOClinical outcome and dosimetric parameters of chemoradiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experienceRadiother Oncol2013107697410.1016/j.radonc.2013.04.006Open DOISearch in Google Scholar

Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan LT, Gillham C, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol 2016; 120: 434-40. 10.1016/j.radonc.2016.03.020FokdalLSturdzaAMazeronRHaie-MederCTanLTGillhamCImage guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE studyRadiother Oncol20161204344010.1016/j.radonc.2016.03.020Open DOISearch in Google Scholar

eISSN:
1581-3207
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology